PRISMA-P 2015 作者依从性与使用体验:横断面研究
该研究从 PubMed 与 OSF/PROSPERO 各随机抽取 50 份系统评价方案,评估对 PRISMA-P 2015 全部 26 个条目的依从性,并访谈 15 位方案作者。PubMed 方案完全报告适用条目的中位比例为 60%(IQR 52%-64%),OSF/PROSPERO 为 45%(IQR 38%-58%);两类方案中均有 6 个条目在超过 25% 的方案中未被报告。
要点
- PubMed 方案对 PRISMA-P 条目的完全报告率高于 OSF/PROSPERO 方案。
- 方案修订、资助者角色、定量合成标准等 6 个条目常被漏报。
- 访谈作者建议增补利益冲突等内容并细化无荟萃分析时的报告指引。
核心结论
- 在 50 份 PubMed 系统评价方案和 50 份 OSF/PROSPERO 方案中,对部分 PRISMA-P 2015 条目的依从性偏低,OSF/PROSPERO 方案更低。
- 两类方案中均有 6 个条目在超过 25% 的方案中未被报告,访谈作者提出了多种更新建议,将用于 PRISMA-P 2015 的后续修订。
研究设计与样本
- 横断面研究,从 2021 年 5 月至 2024 年 5 月随机抽取 100 份互不重叠的系统评价方案,其中 50 份来自 PubMed 收录期刊、50 份来自 OSF/PROSPERO。
- 两名作者独立按 26 个 PRISMA-P 2015 条目评定为完全报告、部分报告或未报告(或不适用),并按两类方案分别分析依从性。
主要发现
- PubMed 的 50 份方案中,完全报告的适用 PRISMA-P 条目比例中位数为 60%(IQR 52%-64%)。
- OSF/PROSPERO 的 50 份方案中,完全报告的适用条目比例中位数为 45%(IQR 38%-58%)。
- 两类方案中均有 6 个条目在超过 25% 的方案中未被报告:方案修订、资助者角色、定量合成标准、除定量荟萃偏倚外的计划汇总方法、对累积证据的信心。
- 两类方案中均有 11 个条目在超过 25% 的方案中被部分报告。
- 访谈建议多为增加或修改现有内容,如报告利益冲突、明确无荟萃分析时如何报告数据合成,以及添加 Elaboration and Explanation 论文链接等。
临床怎么用
- 使用 PRISMA-P 2015 撰写或评审系统评价方案时,应重点核查常被漏报的 6 个条目与常被部分报告的 11 个条目。
- 可参考本研究访谈建议,在方案中明确利益冲突与无荟萃分析时的数据合成报告方式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study aimed to explore systematic review protocol authors' adherence to and experiences with the Preferred Reporting Items for Systematic reviews and Meta-Analyses Protocols (PRISMA-P) 2015 reporting guideline. METHODS: We randomly sampled 100 non-overlapping systematic review protocols from May 2021 to May 2024: 50 from PubMed-indexed journals and 50 from Open Science Framework (OSF)/the International Prospective Register of Systematic Reviews (PROSPERO). Two authors independently assessed adherence to the 26 PRISMA-P 2015 items as fully, partially (ie, when some, but not all, aspects of an item were reported according to predefined criteria), or not reported (or not applicable). We analysed adherence within the 2 protocol types separately. Forty-three systematic review protocol authors were invited for interviews on their experiences with using PRISMA-P 2015. We used a semistructured interview guide, involving 3 prespecified themes: level of experience, views on using PRISMA-P 2015, and reflections on the guideline's strengths and challenges. We applied framework analysis to the interview transcripts. RESULTS: Among the 50 PubMed protocols, the median proportion of fully reported applicable PRISMA-P items was 60% (IQR 52%-64%). The median proportion for OSF/PROSPERO protocols was 45% (IQR 38%-58%). Across both types of protocols, >25% were found not to report 6 items: protocol amendments, role of funder, criteria for quantitative synthesis, methods for planned summary other than quantitative meta-bias(es), and confidence in the cumulative evidence. In both types of protocols, >25% were found to partially report 11 items. Fifteen authors participated in the interviews. Through the interviews, suggestions for updating PRISMA-P 2015 emerged. Most suggestions concerned either adding or modifying existing content, for example, to report conflicts of interest, or clarify guidance on how to report data synthesis when no meta-analysis is planned; other suggestions were more general, for example, to add links to the Elaboration and Explanation paper. CONCLUSION: Adherence to some PRISMA-P 2015 items was low among 50 PubMed systematic review protocols and even lower among 50 OSF/PROSPERO protocols. Six items were often not reported across both types of protocols. The interviewed authors suggested various additions and modifications to the guideline. Findings from this study provide context for users of the reporting guideline and will inform a forthcoming update of PRISMA-P 2015. PLAIN LANGUAGE SUMMARY: Researchers collect and summarise findings from several studies to better understand a specific health issue. These summaries are called systematic reviews. Health care guidelines are often based on results from systematic reviews. This makes systematic reviews very important for health care professionals and patients. To make sure that these results can be trusted and used, systematic reviews need to be done in a clear way. It needs to be so clear that other researchers can understand and repeat it. One way to do this is to write in detail how the review is planned before starting it. This is called a protocol. It can be useful with a guide to help authors write protocols with enough details. Such a guideline for writing protocols exists and is called PRISMA-P. It includes a checklist of 26 different items that should be described in a protocol. However, research shows that authors may not follow such guidelines closely. So far, no research has looked at how protocol authors use PRISMA-P or what makes it easier or harder to follow. In our study, we wanted to explore how protocol authors use PRISMA-P and what they think about it. We checked 100 protocols to see how well all 26 PRISMA-P items were described. We also interviewed 15 protocol authors about how they use PRISMA-P and if they had suggestions for improving it. We found that in more than 25% of the protocols, 6 specific items were not described. We also found that in more than 25% of the protocols, 11 other items were only partially described. The interviewed authors suggested many ways to improve PRISMA-P. For example, they suggested making instructions clearer on how to follow the individual items. They also suggested adding new content to PRISMA-P. Our findings will make it easier to read, write, and evaluate protocols for systematic reviews. The findings can also be used for a future update of PRISMA-P.
引用
- Engmose MB, Chan AW, Dwan K, et al. Author adherence and experiences with PRISMA-P 2015: a cross-sectional study. J Clin Epidemiol. 2026. PMID: 42214644. doi:10.1016/j.jclinepi.2026.112350
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。